在慢性淋巴细胞白血病当前的治疗序列
Samir Mouhssine1, Nawar Maher1, Sreekar Kogila1
1Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.
Hematology reports
|May 28, 2024
概括
新的慢性淋巴细胞白血病 (CLL) 治疗方法为低风险患者提供了有效的选择. 高风险的CLL管理和复发性/耐药性疾病测序需要进一步的研究以获得最佳的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是最常见的成人白血病,治疗策略不断发展.
- 患者风险分层是至关重要的,基于IGHV突变状态,TP53中断和型.
- 目前的治疗方法正在不断改进.
研究的目的:
- 提供慢性淋巴细胞白血病 (CLL) 当前治疗算法的概述.
- 讨论前治疗和复发/耐性CLL患者的治疗策略.
- 突出CLL管理中的挑战和进步.
主要方法:
- 对当前临床指导方针和关于CLL治疗的出版文献的审查.
- 对包括BCL2抑制剂和BTK抑制剂 (BTKi) 在内的向疗法的疗效数据的分析.
- 对不同风险类别和疾病状态的治疗顺序建议的综合.
主要成果:
- 对于低风险和中等风险的,以前没有接受过治疗的CLL,venetoclax加上obinutuzumab和第二代BTKi (acalabrutinib,zanubrutinib) 是有效的第一线选择.
- 高风险的CLL患者从固定时间的venetoclax疗法中获得了有限的益处;持续的BTKi显示出了有利的结果.
- 复发性/耐药性CLL的确立治疗序列包括BTKi耐药病例的venetoclax加Rituximab,以及BTKi耐药性早期复发的第二代BTKi.
结论:
- 治疗CLL是动态的,针对不同的风险群体和疾病阶段有不同的策略.
- 管理获得的耐药性和优化治疗顺序仍然是CLL治疗的关键挑战.
- 目前的数据支持针对新诊断和复发/耐药性CLL的特定治疗算法.
关键词:
在CAR-T细胞中.这是一个calabrutinib.慢性淋巴细胞白血病 慢性淋巴细胞白血病处理过程中的折射性.治疗顺序的顺序处理.维尼托克莱克斯 (Venetoclax) 是一个赞努布鲁丁尼布 (Zanubrutinib) 是一种药物.更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.7K
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K